<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://freemwiki.com/index.php?action=history&amp;feed=atom&amp;title=Openai%2F6966e871-a3c0-8012-ad81-1877ae7fcbdb</id>
	<title>Openai/6966e871-a3c0-8012-ad81-1877ae7fcbdb - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://freemwiki.com/index.php?action=history&amp;feed=atom&amp;title=Openai%2F6966e871-a3c0-8012-ad81-1877ae7fcbdb"/>
	<link rel="alternate" type="text/html" href="https://freemwiki.com/index.php?title=Openai/6966e871-a3c0-8012-ad81-1877ae7fcbdb&amp;action=history"/>
	<updated>2026-05-04T16:17:44Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.3</generator>
	<entry>
		<id>https://freemwiki.com/index.php?title=Openai/6966e871-a3c0-8012-ad81-1877ae7fcbdb&amp;diff=595618&amp;oldid=prev</id>
		<title>Lukegao: by freem.ai...</title>
		<link rel="alternate" type="text/html" href="https://freemwiki.com/index.php?title=Openai/6966e871-a3c0-8012-ad81-1877ae7fcbdb&amp;diff=595618&amp;oldid=prev"/>
		<updated>2026-01-15T05:29:21Z</updated>

		<summary type="html">&lt;p&gt;by freem.ai...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&lt;br /&gt;
{{DISPLAYTITLE:BCG Vaccine and T1D}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;This conversation was exported from ChatGPT&amp;#039;&amp;#039;&amp;lt;ref&amp;gt;{{cite web|title=BCG Vaccine and T1D|url=https://chatgpt.com/share/6966e871-a3c0-8012-ad81-1877ae7fcbdb|publisher=ChatGPT|access-date=2026-01-15}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== gpt-5-2 ==&lt;br /&gt;
=== User: summarize this study ===&lt;br /&gt;
summarize this study&lt;br /&gt;
&lt;br /&gt;
=== Assistant: Here’s a clear, plain-English summary of the study, with the key takeaways and why it matters: ===&lt;br /&gt;
Here’s a clear, plain-English summary of the study, with the key takeaways and why it matters:&lt;br /&gt;
&lt;br /&gt;
==== Summary of the Study ====&lt;br /&gt;
&lt;br /&gt;
What was studied&lt;br /&gt;
This study investigated how the Bacillus Calmette-Guérin (BCG) vaccine lowers blood sugar in people with long-standing type 1 diabetes (T1D)—despite the absence of insulin production. Specifically, the researchers wanted to identify which organ(s) are responsible for the increased glucose uptake seen after BCG treatment bcg-T1D-spleen-study&lt;br /&gt;
&lt;br /&gt;
.&lt;br /&gt;
&lt;br /&gt;
==== Study Design ====&lt;br /&gt;
* Human trial: - 6 adults with long-standing T1D received repeated BCG vaccinations over 2 years. - Researchers used ¹⁸F-FDG PET/CT scans to track glucose uptake in different organs before and after BCG. - Blood sugar control was monitored using HbA1c, and insulin production was checked via C-peptide.&lt;br /&gt;
* Mouse experiments: - Mice were injected with BCG and sacrificed at intervals up to 20 weeks. - Organs were cultured to see where live BCG bacteria persisted.&lt;br /&gt;
&lt;br /&gt;
==== Key Findings ====&lt;br /&gt;
&lt;br /&gt;
===== 1. BCG significantly lowers blood sugar — without restoring insulin =====&lt;br /&gt;
* HbA1c dropped by ~10% over time, reaching near-normal levels.&lt;br /&gt;
* C-peptide remained near zero, confirming the effect was not due to insulin recovery bcg-T1D-spleen-study .&lt;br /&gt;
&lt;br /&gt;
===== 2. BCG shifts immune cells to high-glucose consumption =====&lt;br /&gt;
* BCG reprograms immune cells (monocytes, T cells, lymphocytes) to favor aerobic glycolysis (the “Warburg effect”).&lt;br /&gt;
* This causes immune cells to pull more glucose out of the bloodstream.&lt;br /&gt;
&lt;br /&gt;
===== 3. The spleen is the dominant organ driving glucose uptake =====&lt;br /&gt;
* Among all organs studied (spleen, liver, bone marrow, lungs, muscle, brain): - Only the spleen showed a sustained, statistically significant increase in glucose uptake - The spleen’s glucose uptake increased by ~47% over two years bcg-T1D-spleen-study .&lt;br /&gt;
&lt;br /&gt;
===== 4. Mouse data confirm the spleen as the key BCG niche =====&lt;br /&gt;
* Live BCG bacteria were found: - Persistently in the spleen (up to 20 weeks) - Transiently in bone marrow and liver - Rarely in lungs or muscle&lt;br /&gt;
* The organ distribution of live BCG in mice closely matched the glucose-uptake patterns seen in humans.&lt;br /&gt;
&lt;br /&gt;
==== Why This Matters ====&lt;br /&gt;
* The spleen is one of the largest immune organs in the body, packed with glucose-hungry lymphocytes.&lt;br /&gt;
* Once reprogrammed by BCG, the spleen becomes a major systemic glucose sink, helping normalize blood sugar even without a functioning pancreas.&lt;br /&gt;
* This helps explain how BCG can improve glycemic control in T1D—something previously difficult to justify based on blood immune cells alone.&lt;br /&gt;
&lt;br /&gt;
==== Big Picture Conclusion ====&lt;br /&gt;
&lt;br /&gt;
: BCG transforms the spleen into a new regulator of blood glucose.&lt;br /&gt;
&lt;br /&gt;
The study provides strong evidence that:&lt;br /&gt;
* The immune system—specifically the spleen—can meaningfully regulate blood sugar&lt;br /&gt;
* BCG’s long-term metabolic effects are driven by immune-cell reprogramming, not insulin&lt;br /&gt;
* This mechanism may have implications beyond type 1 diabetes, including other autoimmune or metabolic diseases bcg-T1D-spleen-study .&lt;br /&gt;
&lt;br /&gt;
If you want, I can also:&lt;br /&gt;
* Give a 1-paragraph layperson version&lt;br /&gt;
* Break down strengths vs limitations&lt;br /&gt;
* Explain why this study is controversial&lt;br /&gt;
* Compare this to standard diabetes treatments&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Category:ChatGPT Shares]]&lt;br /&gt;
[[Category:openai]]&lt;/div&gt;</summary>
		<author><name>Lukegao</name></author>
	</entry>
</feed>